PubMed Health⌕ Search
Home/Archive/PubMed

PubMed · 16936906

Guanylins--agents with natriuretic effect.

Pavlina Solichova·David Stejskal·Jitka Proskova
View original source ↗Export metadata ↓

Abstract

Guanylins and uroguanylins are natriuretic peptides with different effects in many of tissues. In context with guanylins, the intestine-renal axis is presented. The overproduction of guanylin or uroguanylin leads to secondary diarrhea with stimulation of Cl(-) secretion. A diet high in salt lead especially to increased guanylin and uroguanylin secretion. Interesting applications with guanylins measurement could to be in hypertension diagnosis, monitoring of heart dysfunction treatment, intensive care etc.

Explore related subjects

Gastrointestinal HormonesHumansNatriuretic PeptidesJournal ArticleReview

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Pavlina Solichova, David Stejskal, Jitka Proskova. 2006. Guanylins--agents with natriuretic effect.. https://doi.org/10.5507/bp.2006.010

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

PubMed2005

The physiological role of GLP-1 in human: incretin, ileal brake or more?

The proglucagon-derived peptide glucagon-like peptide-1 (GLP-1) is an intestinal signal peptide postprandially released from the L cells of the lower gut. Exogenously administered the synthetic hormone exerts a glucose-dependent insulinotropic effect at the pancreatic beta-cells and lowers plasma glucagon by an inhibitory effect against the alpha-cells. It delays gastric emptying by relaxation of the gastric fundus, inhibition of antral contractility, and stimulation of both the tonic and phasic motility of the pyloric sphincter. Enhancement of insulin, suppression of glucagon, and inhibition of gastric emptying are the main determinants controlling glucose homeostasis with GLP-1. Human studies employing the specific GLP-1 receptor antagonist exendin(9-39) show that endogenously released GLP-1 likewise controls fasting plasma glucagon, stimulates insulin, and influences all the motoric mechanisms known to control gastric emptying. Therefore, GLP-1 is discussed as an incretin hormone and as an enterogastrone in man. Synthetic GLP-1 also suppresses gastric acid and pancreatic enzyme secretion. The inhibitory effects on upper gastrointestinal functions are at least partly mediated by vagal-cholinergic inhibition and may involve interactions with vagal afferent pathways and/or circumventricular regions within the CNS. GLP-1 is a candidate humoral mediator of the 'ileal brake' exerting inhibition of upper gastrointestinal function preventing malabsorption and postprandial metabolic disturbances. As human studies indicate a central action of GLP-1 in reduction of food intake, it is uncertain if this is a consequence of induction of satiety or of transduction of visceral aversive stress signals.

Gastrointestinal Hormones↗
PubMed2004

[Clinical importance of gut hormones].

The lecture includes materials on gut hormones. Descriptions of the main synthesis places as well as structure and functions of hormones are given. The introduction of radioimmunoassay and immunoenzyme techniques to clinical practice made it possible to reach a success in the field of studying gastrointestinal hormones. Basic gut hormones and their role in the control over functioning digestive system and body as a whole under normal and pathological conditions are given.

Gastrointestinal Hormones↗